Overview

Safety and Efficacy of WIN-901X in Asthma

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This clinical trial is designed to evaluate the efficacy, dose-response and safety of WIN-901X in Asthma patients.
Phase:
Phase 2
Details
Lead Sponsor:
Whanin Pharmaceutical Company